Skip to main content

Table 1 Participant demographic and clinical characteristics at enrolment

From: Potential application of the haematology analyser XN-31 prototype for field malaria surveillance in Kenya

  Total enrolled (n = 169)
Age; median (IQR) 23 (5–36)
Male; n (%) 75 (44)
Febrile subjects (37.5); n (%) 33 (19.8)
Duration of fever (days); median (IQR) 3 (2–3)
Having chronic conditions; n (%) 13 (7.7)
Took antimalarials in the last one month; n (%) 13 (7.7)
Travelled in the last 3 months; n (%) 13 (7.7)
Slept under a bed net in previous night; n (%) 155 (91.7)
Covered by IRS programme for the last one year; n (%) 119 (70.4)
Enrolled in RTS,S vaccine trial; n (%) 3 (1.9)
Pregnancy; n (% of total female) 4 (2.4)
Haematological parameters*
White blood cell (103/μL); median (IQR) 5.93 (4.82–8.93)
Red blood cell (106/μL); median (IQR) 5.04 (4.67–5.46)
Haemoglobin (g/dL); median (IQR) 13.1 (11.5–14.2)
Anaemia (Hb < 11 g/dL); n (%) 34 (20.1)
Haematocrit (%); median (IQR) 39.8 (34.6–43.1)
Platelets (103/μL); median (IQR) 256 (197–364)
Thrombocytopenia (< 150 × 103/μL); n (%) 14 (8.3)
  1. *Measured with venous blood in LM mode on the XN-31p